Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Interim Commissioner: Manager or Scientist?

Executive Summary

FDA Chief Scientist Frank Torti fits the profile of an interim commissioner if the incoming administration wants a caretaker with a solid scientific stature and also little baggage of the past regime

You may also be interested in...



FDA Chief Scientist Post A Chance For Califf To Make Mark

Agency seeks candidates for the executive position in charge of its research policy apparatus.

Frank Torti’s Next 100 Days: Active, Not Just Acting FDA Commissioner

Frank Torti might not be in charge of FDA for very long, but he seems determined to make his time count

FDA’s Torti Tapped As Acting Commissioner; Interim Heads Also Named For HHS, CMS

Chief scientist Frank Torti is a relative newcomer to FDA, having joined less than a year ago from Wake Forest University. Since then, he has headed the agency’s successful fellowship program.

Related Content

UsernamePublicRestriction

Register

PS050471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel